Solifenacin succinate
Table of contents of the leaflet:
The active substance of Solifenacin SaneXcel belongs to a group of cholinolytic medicines. These medicines reduce the activity of an overactive bladder. This action allows for longer intervals between using the toilet and increases the amount of urine held in the bladder. Solifenacin SaneXcel is used to treat symptoms of an overactive bladder. These include: urgent urination, i.e., episodes of sudden, urgent need to urinate, frequent urination, and urinary incontinence, related to the fact that the patient did not have time to use the toilet.
Before starting treatment with Solifenacin SaneXcel, the patient should inform their doctor if any of the above situations are currently present or have occurred in the past.
Before starting to take Solifenacin SaneXcel, the patient should discuss it with their doctor, pharmacist, or nurse:
Before starting treatment with Solifenacin SaneXcel, the patient should inform their doctor if any of the above situations are currently present or have occurred in the past. Before starting to take Solifenacin SaneXcel, the doctor will assess whether there are other causes of frequent urination (e.g., heart failure - insufficient strength of the heart muscle to pump blood or kidney disease). If a urinary tract infection occurs, the doctor will prescribe an antibiotic (an antibacterial medicine, effective against specific bacterial infections).
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. It is especially important to inform the doctor if the patient is taking:
Solifenacin SaneXcel can be taken with or without food, depending on the patient's preference.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine. Pregnancy Solifenacin SaneXcel should not be used during pregnancy, unless it is absolutely necessary. Breastfeeding Solifenacin SaneXcel should not be used during breastfeeding, as solifenacin passes into human milk.
Solifenacin may cause blurred vision and sometimes drowsiness or fatigue. If such side effects occur, the patient should not drive or operate machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking this medicine.
This medicine should always be taken as directed by the doctor or pharmacist. If the patient has any doubts, they should consult their doctor or pharmacist. The tablet should be swallowed whole, with a drink of liquid. The medicine can be taken with or without food, depending on the patient's preference. The tablets should not be crushed. The usual dose is 5 mg per day, unless the doctor recommends taking a dose of 10 mg per day.
In case of taking too high a dose of Solifenacin SaneXcel or if a child accidentally swallows the medicine, the patient should immediately contact their doctor or pharmacist. Symptoms of overdose may include: headache, dry mouth, dizziness, drowsiness, and vision disturbances, perceiving things that are not there (hallucinations), excessive excitement, seizures (convulsions), breathing difficulties, rapid heartbeat (tachycardia), urinary retention, and pupil dilation.
In case of missing a dose, the patient should take the next dose as soon as possible, unless it is almost time for the next dose. The medicine should not be taken more than once a day. If the patient has any doubts, they should consult their doctor or pharmacist.
In case of stopping Solifenacin SaneXcel, the symptoms of an overactive bladder may return or worsen. The patient should always consult their doctor if they are considering stopping treatment. If the patient has any further doubts about taking this medicine, they should consult their doctor, pharmacist, or nurse.
Like all medicines, Solifenacin SaneXcel can cause side effects, although not everybody gets them. If the patient experiences an allergic reaction or a severe skin reaction (e.g., blistering and peeling of the skin), they should immediately inform their doctor or pharmacist. Some patients taking solifenacin succinate have reported angioedema (a form of skin allergy that causes swelling of the tissue just below the skin surface) with swelling of the airways (difficulty breathing). If the patient experiences angioedema, they should immediately stop taking Solifenacin SaneXcel and initiate appropriate treatment and/or take appropriate measures. Solifenacin SaneXcel may cause other side effects, including:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (frequency cannot be estimated from the available data):
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the carton and blister after EXP. The expiry date refers to the last day of the month. There are no special precautions for storing the medicine. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Each 10 mg film-coated tablet contains 10 mg of solifenacin succinate, which corresponds to 7.5 mg of solifenacin.
10 mg tablets: Core of the tablet: cornstarch, lactose monohydrate, hypromellose, and magnesium stearate The coating of the tablet: hypromellose, talc, titanium dioxide (E 171), macrogol, and red iron oxide (E 172).
5 mg: Yellow, round, and convex film-coated tablets. 10 mg: Light pink, round, and convex film-coated tablets. Solifenacin SaneXcel film-coated tablets are available in blisters containing 30 or 100 tablets. Not all pack sizes may be marketed.
Marketing authorization holder J.J. Bishop Health a.s. Rybná 682/14, Staré Město 110 00 Prague 1 Czech Republic e-mail: pharmacovigilance@jjbishop.eu Manufacturer Atlantic Pharma – Produções Farmacêuticas, S.A. Rua de Tapada Grande 2, Abrunheira 2710-228 Sintra Portugal
Czech Republic: Solifenacin SaneXcel Poland: Solifenacin SaneXcel Portugal: Solifenacina JJ Bishop Slovakia: Solifenacin SaneXcel
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.